The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2015 ACR/ARHP Annual Meeting: How to Identify, Manage Metabolic Myopathies & Their Mimics

2015 ACR/ARHP Annual Meeting: How to Identify, Manage Metabolic Myopathies & Their Mimics

March 15, 2016 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Other mimics are the muscular dystrophies, a diverse group of inherited disorders of muscle sarcolemmal proteins with dystrophic changes seen on muscle biopsy, usually marked by progressive muscle weakness. The gold standard for diagnosis is identifying the genetic defect.

You Might Also Like
  • Metabolic Myopathies
  • ACR/ARHP Annual Meeting 2012: Use a Combination of Tests, Patient History, and Physical Exam when Assessing Myopathies
  • 2015 ACR/ARHP Annual Meeting: Metabolic Pathways Linked with Inflammatory Diseases
Explore This Issue
March 2016
Also By This Author
  • These Digital Tools Aren’t Just Hype, Can Actually Help Rheumatologists

Energy Source for Muscle Metabolism

Then, Dr. O’Rourke said, there are metabolic myopathies, and to properly identify and treat these, clinicians need to understand how muscles get their energy.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“You have to have some basic understanding of the biochemistry in order to ask the right clinical questions, as well as to order the right testing to get to the right answer,” he said.

He used the analogy of a hybrid car, with its starter motor for cold starts; gas engine for rapid, mass acceleration but its problems of inefficiency, limited energy capacity and pollution; electric motor for cruising and idling, which is efficient but has limited immediate power; and the transmission, which integrates the power from both of those engines to get the wheels to turn.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

When you first contract a muscle, there is a creatinine kinase (CK) reaction, which produces a very limited amount of stored ATP. This is like the muscle’s starter motor.

“The CK reaction allows you a few extra seconds to create additional ATP to get things going before glycolysis takes over,” Dr. O’Rourke said.

And instead of gasoline, there’s glycogen, which is limited and pollutes, in the absence of sufficient oxygen, in the form of lactic acid. Through glycolysis, glucose is converted into pyruvate, which in the presence of adequate oxygenation is then further metabolized in the Krebs cycle.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The transmission is the electronic transport chain (ETC) that leads to the production of ATP. And the electric motor is essentially the oxidation of fats into pieces that can be used by the ETC to make ATP.

Diagnostic Approach

Dr. O’Rourke suggested two pattern-recognition stages that can be helpful in getting to a diagnosis.

In the first, clinicians should ask a series of questions about symptoms, how long symptoms last, family history, what brings about the muscle fatigue, whether there are associated systemic problems and how the weakness is distributed.

In metabolic myopathies, weakness typically stems from exertion or an infection or from eating or fasting, and is episodic. Because the majority of these diseases are mainly autosomal recessive, there may be no known family history.

The other recognition stage, he said, is assessing for changes on either side of the clog or metabolic block. In these disorders, because there is a breakdown in metabolic processing, levels of whatever is not being processed properly should be higher than normal on one side of the clog, and the product of that process should be lower than normal on the other.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Meeting Reports, Soft Tissue Pain Tagged With: 2015 ACR/ARHP Annual Meeting, American College of Rheumatology, Diagnosis, metabolic, muscle, Myopathy, myositis, patient care, rheumatologistIssue: March 2016

You Might Also Like:
  • Metabolic Myopathies
  • ACR/ARHP Annual Meeting 2012: Use a Combination of Tests, Patient History, and Physical Exam when Assessing Myopathies
  • 2015 ACR/ARHP Annual Meeting: Metabolic Pathways Linked with Inflammatory Diseases
  • ACR 2013 State-of-the-Art Clinical Symposium: How to Identify Signs of Myositis and Metabolic Myopathies

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.